BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35504971)

  • 1. Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
    Reijns MAM; Parry DA; Williams TC; Nadeu F; Hindshaw RL; Rios Szwed DO; Nicholson MD; Carroll P; Boyle S; Royo R; Cornish AJ; Xiang H; Ridout K; ; ; Schuh A; Aden K; Palles C; Campo E; Stankovic T; Taylor MS; Jackson AP
    Nature; 2022 May; 605(7910):E7. PubMed ID: 35504971
    [No Abstract]   [Full Text] [Related]  

  • 2. Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
    Reijns MAM; Parry DA; Williams TC; Nadeu F; Hindshaw RL; Rios Szwed DO; Nicholson MD; Carroll P; Boyle S; Royo R; Cornish AJ; Xiang H; Ridout K; ; ; Schuh A; Aden K; Palles C; Campo E; Stankovic T; Taylor MS; Jackson AP
    Nature; 2022 Feb; 602(7898):623-631. PubMed ID: 35140396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotides and Transcription-Associated Mutagenesis in Yeast.
    Cho JE; Jinks-Robertson S
    J Mol Biol; 2017 Oct; 429(21):3156-3167. PubMed ID: 27511624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct mechanisms of Topoisomerase 1-dependent mutagenesis in yeast.
    Cho JE; Kim N; Li YC; Jinks-Robertson S
    DNA Repair (Amst); 2013 Mar; 12(3):205-11. PubMed ID: 23305949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for topoisomerase 1 in transcription-associated mutagenesis in yeast.
    Lippert MJ; Kim N; Cho JE; Larson RP; Schoenly NE; O'Shea SH; Jinks-Robertson S
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):698-703. PubMed ID: 21177427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Top1 paradox: Friend and foe of the eukaryotic genome.
    Kim N; Jinks-Robertson S
    DNA Repair (Amst); 2017 Aug; 56():33-41. PubMed ID: 28641942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic localization of DNA topoisomerase I and its functional relevance during Drosophila development.
    Huang W; Liu Z; Rong YS
    G3 (Bethesda); 2021 Sep; 11(9):. PubMed ID: 34544118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase I in Human Disease Pathogenesis and Treatments.
    Li M; Liu Y
    Genomics Proteomics Bioinformatics; 2016 Jun; 14(3):166-171. PubMed ID: 27181710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizure suppression by top1 mutations in Drosophila.
    Song J; Hu J; Tanouye M
    J Neurosci; 2007 Mar; 27(11):2927-37. PubMed ID: 17360915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase I alone is sufficient to produce short DNA deletions and can also reverse nicks at ribonucleotide sites.
    Huang SY; Ghosh S; Pommier Y
    J Biol Chem; 2015 May; 290(22):14068-76. PubMed ID: 25887397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.
    Husain A; Begum NA; Taniguchi T; Taniguchi H; Kobayashi M; Honjo T
    Nat Commun; 2016 Feb; 7():10549. PubMed ID: 26842758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.
    Montaudon D; Palle K; Rivory LP; Robert J; Douat-Casassus C; Quideau S; Bjornsti MA; Pourquier P
    J Biol Chem; 2007 May; 282(19):14403-12. PubMed ID: 17355975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.
    Baranello L; Wojtowicz D; Cui K; Devaiah BN; Chung HJ; Chan-Salis KY; Guha R; Wilson K; Zhang X; Zhang H; Piotrowski J; Thomas CJ; Singer DS; Pugh BF; Pommier Y; Przytycka TM; Kouzine F; Lewis BA; Zhao K; Levens D
    Cell; 2016 Apr; 165(2):357-71. PubMed ID: 27058666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian period.
    Onishi Y; Kawano Y
    Nucleic Acids Res; 2012 Oct; 40(19):9482-92. PubMed ID: 22904072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron.
    Reinhold WC; Mergny JL; Liu H; Ryan M; Pfister TD; Kinders R; Parchment R; Doroshow J; Weinstein JN; Pommier Y
    Cancer Res; 2010 Mar; 70(6):2191-203. PubMed ID: 20215517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation.
    Kobayashi M; Sabouri Z; Sabouri S; Kitawaki Y; Pommier Y; Abe T; Kiyonari H; Honjo T
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19305-10. PubMed ID: 22080610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Topoisomerase (TOP1 and TOP2α) Expression in Patients With Breast Cancer.
    Ogino M; Fujii T; Nakazawa Y; Higuchi T; Koibuchi Y; Oyama T; Horiguchi J; Shirabe K
    In Vivo; 2020; 34(6):3483-3487. PubMed ID: 33144457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage-defective Topoisomerase I mutants sharply increase G-quadruplex-associated genomic instability.
    Berroyer A; Bacolla A; Tainer JA; Kim N
    Microb Cell; 2022 Mar; 9(3):52-68. PubMed ID: 35291312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Publisher Correction: Gene expression levels modulate germline mutation rates through the compound effects of transcription-coupled repair and damage.
    Xia B; Yanai I
    Hum Genet; 2022 Oct; 141(10):1695. PubMed ID: 36149497
    [No Abstract]   [Full Text] [Related]  

  • 20. Apn2 resolves blocked 3' ends and suppresses Top1-induced mutagenesis at genomic rNMP sites.
    Li F; Wang Q; Seol JH; Che J; Lu X; Shim EY; Lee SE; Niu H
    Nat Struct Mol Biol; 2019 Mar; 26(3):155-163. PubMed ID: 30778235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.